ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
4.95%
1 Year Est. Return
+4.95%
AUM
$17.4M
AUM Growth
-$93.9M
(-84%)
Holding
52
Top Buys
| 1 | +$1.55M | |
| 2 | +$1.04M | |
| 3 | +$906K | |
| 4 |
Encompass Health
EHC
|
+$859K |
| 5 |
Pfizer
PFE
|
+$455K |
Top Sells
| 1 | +$16.9M | |
| 2 | +$6.93M | |
| 3 | +$6.53M | |
| 4 |
Thermo Fisher Scientific
TMO
|
+$5.34M |
| 5 |
Elevance Health
ELV
|
+$5.13M |
Sector Composition
| 1 | Healthcare | 98.36% |
| 2 | Real Estate | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
10x Genomics
TXG
$2.27B
| – | – |
-71,044
|
|
||
52
Ventyx Biosciences
VTYX
$567M
| – | – |
-18,458
|
|